4.85
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
Unicycive Therapeutics Announces the Publication of Oxylanthanum Carbonate Pivotal Trial Data in Clinical Journal of the American Society of Nephrology - The Manila Times
Revolutionary Kidney Disease Drug Shows 90% Success Rate with Just 3 Pills Daily, New Study Reveals - Stock Titan
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Unicycive Therapeutics Inc. a good long term investmentFree Market Dynamics Reports - jammulinksnews.com
What drives Unicycive Therapeutics Inc. stock priceOver 200% growth - jammulinksnews.com
Unicycive Therapeutics Inc. Stock Analysis and ForecastFree Smart Trading Workshop - jammulinksnews.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - WV News
Is Unicycive Therapeutics (NASDAQ:UNCY) In A Good Position To Invest In Growth? - Yahoo Finance
What analysts say about Unicycive Therapeutics Inc. stockExceptional market performance - jammulinksnews.com
Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Investors to Inquire about Securities Investigation - ACCESS Newswire
Best Stocks for a Post COVID Recovery in India Financial Expert RecommendationsFree Stock Market Trend Analysis - PrintWeekIndia
What analysts say about Palladyne AI Corp. stockRapid growth trajectories - jammulinksnews.com
EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm - Business Wire
Published on: 2025-07-18 04:29:16 - Newser
Why Unicycive Therapeutics Inc. stock is on top investor watchlistsDaily Top Gainers - Newser
Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionFast Moving Stock Alerts - Newser
How Unicycive Therapeutics Inc. stock performs during market volatilityReal Chart Play - Newser
What makes Unicycive Therapeutics Inc. stock price move sharplyFree Trading Strategy Suggestions - Newser
Transcript : Unicycive Therapeutics, Inc. Presents at H.C. Wainwright 4th Annual Kidney Virtual Conference, Jul-14-2025 11 - MarketScreener
Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference - 富途牛牛
Pomerantz LLP Investigates Unicycive Therapeutics Securities Fraud Claims. - AInvest
Unicycive Regains Nasdaq Compliance After Stock Split - The Globe and Mail
Unicycive regains Nasdaq compliance after reverse stock split By Investing.com - Investing.com South Africa
Unicycive regains Nasdaq compliance after reverse stock split - Investing.com
Unicycive Therapeutics Regains Compliance with Nasdaq Listing Standards Following Share Price Recovery - Quiver Quantitative
Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Unicycive Successfully Maintains Nasdaq Listing Following 1:10 Reverse Stock Split - Stock Titan
Unicycive Therapeutics (NASDAQ:UNCY) Trading 2% Higher – Time to Buy? - Defense World
Unicycive Therapeutics to Participate in H.C. Wainwright 4th Annual Kidney Virtual Conference - Nasdaq
Clinical-Stage Kidney Disease Biotech Unicycive Reveals Latest Therapeutic Progress at Major Healthcare Conference - Stock Titan
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Unicycive Therapeutics - The Pharma Letter
Unicycive Shares Sink After FDA Issues Response Letter on Kidney Drug Filing - MSN
Ongoing Unicycive Therapeutics, Inc. (UNCY) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire
Ongoing Securities Investigation Into Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky - ACCESS Newswire
Unicycive stock falls as FDA plans complete response letter for OLC - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):